CALL/FRESENIUS MEDICAL CARE/30/0.1/21.06.24 Share Price

Warrant

DE000GK9NX73

Real-time BOERSE MUENCHEN 15:25:45 19/06/2024 BST
0.61 EUR -14.08% Intraday chart for CALL/FRESENIUS MEDICAL CARE/30/0.1/21.06.24
Current month-23.66%
1 month-33.64%
Date Price Change
19/06/24 0.61 -14.08%
18/06/24 0.71 -2.74%
17/06/24 0.73 -16.09%
14/06/24 0.87 -2.25%
13/06/24 0.89 -11.88%

Real-time BOERSE MUENCHEN

Last update June 19, 2024 at 03:25 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer Goldman Sachs
WKN GK9NX7
ISINDE000GK9NX73
Date issued 26/08/2022
Strike 30
Maturity 21/06/2024 (2 Days)
Parity 10 : 1
Emission price 0.84
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.12
Lowest since issue 0.421
Spread 0.05
Spread %7.35%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.26 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.24%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW